Brainever

Brainever is a biotech company in Paris, France, founded in 2015. It has raised $36.3M across 1 round, most recently a $36.3M Series B in July 2025.

Homeoprotein Therapies for ALS, Parkinson’s, Retina

Headquarters
Paris
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$36.3M
Last Round
$36.3M Series BJul 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

BrainEver is a Paris-based biopharmaceutical company developing a pipeline of novel therapies for patients suffering from age-related neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease, and retinal conditions. Its approach, based on homeoprotein biology, aims to halt disease progression by stopping neuronal death and durably modifying the physiology and metabolism of surviving neurons. The company secured €33M in Series B funding to advance Europe's first clinical trial of its ALS treatment.

Summary

It lists 1–10 employees. It has raised $36.3M in total across 1 round, most recently a $36.3M Series B round in Jul 2025. Investors include Critical Path, European Innovation Council Fund and iBionext.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJul 2025
$36.3M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Brainever on Indexed.vc
<a href="https://indexed.vc/companies/brainever"><img src="https://indexed.vc/api/badge/company/brainever" alt="Brainever on Indexed.vc" width="260" height="76" /></a>